Vibrio vulnificus cytolysin (VVC) has been implicated as one of the important virulence determinants of V. vulnificus that causes serious septicemia and wound infection. An attempt was made to investigate that VVC could act as a ligand which stimulates intracellular signaling systems. Cholesterol dose-dependently blocked VVC hemolytic activity through oligomerization of cytolysin. Among cholesterol derivatives including 7-dehydrocholesterol, cholesteryl esters, deoxycholate, and cholestane tested, only 7-dehydrocholesterol induced oligomerization as well as inactivation of VVC. These results show that oligomerization of VVC is completely dependent on three-dimensional structure of cholesterol where specific interaction of cholesterol at oligomerization sites of VVC is very selective. These findings support the idea that cholesterol which constitute many of cellular plasma membrane could be a receptor of VVC on plasma membrane of target cells.
Introduction
The halophilic bacterium Vibrio vulnificus is known to be a life-threatening pathogen that causes septicemia and serious wound infection in human. V. vulnificus infection is characterized by a high fatality rate of 70% and the primary attack against people who are immunocom-promised or have underlying diseases such as liver cirrhosis or hemochromatosis (Hollis et al., 1976; Blake et al., 1979; Park et al., 1991; Oliver et al., 1995) . A variety of factors, including an extracellular cytolysin (Gray and Kreger, 1985) , an elastolytic protease (Miyoshi et al., 1992) , and resistance to phagocytosis (Yoshida et al., 1985) have all been implicated as possible virulence determinants for V. vulnificus septicemia in animal models. Kreger and Lockwood (1981) demonstrated that V. vulnificus cytolysin (VVC) showed hemolytic and lethal activity, and acted as vascular permeability factor. Although a definitive role of VVC in V. vulnificus infection is controversial (Oliver et al., 1986; Wright and Morris, 1991; Fan et al., 2001) , VVC has still been focused because of its pore-forming nature.
VVC shows a high affinity to mammalian cell membranes, indicating that it has a broad spectrum of cytotoxicity against a variety of cells including erythrocytes, neutrophils, mast cells, endothelial cells, and macrophages (Kreger and Lockwood, 1981; Yamanaka et al., 1990; Kim et al., 1993; Park et al., 1994; Chae et al., 1996; Kim, 1997; Kim et al., 1998; Kwon et al., 2001; Kang et al., 2002) . Furthermore, recent data demonstrated that VVC induce mammalian cell activation through production of intracellular signaling molecules such as hydrogen peroxide (H 2 O 2 ) or nitric oxide (NO) (Kwon et al., 2001; Kang et al., 2002) . These reports supported that VVC could act as a ligand which stimulates intracellular signaling systems. With respect to the understanding VVC mediated signal transduction and toxic mechanism, it will be of great interest to identify a membrane receptor of VVC.
It has been known that the lysis of erythrocytes caused by VVC is colloid-osmotic in nature and that VVC, after binding to the erythrocyte membrane, oligomerize to form small pores in the membrane resulting in cell lysis (Kim et al., 1993) . In addition, cholesterol inactivates VVC by converting active monomer cytolysin into inactive oligomer, suggesting that the cytolysin lyses erythrocytes through the formation of small pores on erythrocyte membrane by cholesterol-mediated oligomerization of the cytolysin (Kim et al., 1993) . These results indicate that cholesterol might be a possible receptor for VVC on mammalian cells.
The aim of this study was to investigate the specificity of VVC binding to cholesterol and to propose that cholesterol could be a possible receptor for VVC. This paper shows that VVC recognize only 7-dehydrocholesterol among cholesterol derivatives, suggesting that VVC binds cholesterol with defined structural specificity.
Materials and Methods

Materials
Dulbecco's phosphate buffered saline, BSA, cholesterol derivatives, and DEAE cellulose were purchased from Sigma. (St. Louis. MO). Dulbeccos modified Eagles medium (DMEM), fetal bovine serum (FBS), and heart infusion broth were purchased from Gibco Laboratories (Grand Island, NY). Cytotoxicity detection kit of LDH was purchased from Boehringer Mannheim (Mannheim, Germany). All other reagents were of the highest purity grade available.
Bacterial strain and culture
A virulent strain of V. vulnificus E4125 was kindly supplied by Dr. M. H. Kothary (Department of Microbiology, Virulence Assessment Branch, Center for Food Safety and Applied Nutrition, Food and Drug Administration, Washington D.C.). The strain was cultured in the heart infusion diffusate broth as described by Kreger et al. (1988) .
Assay of hemolytic activity
The hemolytic activity of VVC against mouse erythrocytes was determined by the method of Bernheimer and Schwarz (1963) . VVC was diluted with phosphate-buffered saline (67 mM Na 2 HPO 4 , 77 mM NaCl, pH 7.4) containing 1 mg of BSA per ml (PBS-BSA). One milliliter of VVC was mixed with the same volume of 0.7% mouse erythrocyte suspensions in PBS-BSA. After incubation at 37 o C for 30 min and brief centrifugation, A 545 of hemoglobin in the supernatant was measured. One hemolytic unit (HU) is defined as that amount which liberates half of the hemoglobin in the erythrocyte suspensions.
Preparation of VVC
VVC was purified to homogeneity from the culture supernatant by ammonium sulfate fractionation, calcium phosphate gel adsorption, quaternary methylamine anion-exchange chromatography and octyl-Sepharose CL-4B chromatography as described by Kim et al. (1993) . VVC found to be homogenous on a SDSpolyacrylamide gel. The purified VVC had a specific hemolytic activity of 80,000 HU per mg of protein with 30% recovery.
SDS-PAGE for the detection of VVC oligomer
The oligomer of VVC was detected by a modification of the method developed by Walev et al. (1993) . Samples were prepared with the same volume of 0.5 M Tris buffer (pH 6.8) containing 4% SDS, 20% glycerol and 0.05% bromophenol blue at room temperature. SDS-PAGE was performed in 7.5% slab gel according to Laemmli (1970) . Proteins were detected by staining with Coomassie brilliant blue R 250.
Results and Discussion
Previous data have demonstrated that VVC is inactivated by cholesterol that might be the binding site of VVC (Kim et al., 1993) . Many papers indicate that a few of bacterial toxins are also inactivated by various lipids such as phospholipids, gangliosides, and cholesterol (Takeda et al., 1975; Prigent et al., 1976; Shinoda et al., 1985) . However, clear structural relationship between lipids and toxins are still unknown.
In order to determine the effect of cholesterol on hemolytic activity of VVC, VVC was incubated with various concentrations of cholesterol at 37 o C. After incubation for 30 min, the residual hemolytic activity of VVC was measured (Figure 1 ). Cholesterol inactivated VVC in a concentration-dependent manner, approximately 90% of total activity being disappeared by incubating with 1 µg of cholesterol. Cholesterol treated-VVC was revealed as oligomer when analyzed by SDS-PAGE (Figure 2) . The inactivation of VVC with concomitant formation of oligomer induced by cholesterol indicates that the cholesterol-induced inactivation is due to the consumption of active monomers by oligomerizatioon occurred prior to membrane binding. Accordingly, VVC seems to directly bind to plasma membrane cholesterol, oligomerize and forms a pore.
Thiol-activated toxins such as streptolysin O, tetanolysin, or pneumolysin are known to be inactivated by cholesterol and certain related sterols (Prigent et al., 1976; Johnson et al., 1980) . But VVC is different from those thiol-activated cytolysins because of being stable to oxygen and sulfhydryl blocking agents (Shinoda et al., 1985) . This study was designed to demonstrate that VVC might uniquely interact with cholesterol molecules on plasma membranes of target mammalian cells. In order to determine whether cholesterol structure has effect on oligomerization as well as hemolytic activity of VVC or not, VVC was incubated with phosphatidylcholine or cholesterol derivatives containing a high structural similarity to cholesterol, including 7-dehydrocholesterol, cholesteryl palmitate, cholesteryl myristate, deoxycholate, and cholestane (Figure 3 ). Among these lipids, 7-dehydrocholesterol only inactivated hemolytic activity of VVC (Table 1) . Furthermore, oligomerization of VVC was also induced only by 7-dehydrocholesterol (Figure 4) . These results indicate that molecular interaction between cholesterol and VVC is completely dependent on three- Table 1 . Effect of various lipids on hemolytic activity of VVC. VVC (1.0 HU) was incubated with the various lipids (1 mg) at 37 o C for 30 min in total volume of 1 ml of phosphate-buffered saline containing 1 mg of BSA. The residual hemolytic activity was determined as described in the Materials and Methods. The control activity of VVC without preincubation under these conditions was arbitarily set at 100%. Each value denotes the mean ± SE obtained from five experiments. dimensional structure of cholesterol. Thus, this study strongly suggests that cholesterol serves a binding site of VVC on plasma membrane of target cells.
